<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Patient Care Online articles</title><description>Patient Care Online articles</description><link>https://www.patientcareonline.com/news</link><category>Patient Care Online articles</category><copyright>© 2026 MJH Life Sciences™ and Patient Care Online. All rights reserved.</copyright><lastBuildDate>Thu, 20 Aug 2026 23:23:19 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.patientcareonline.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>Patient Care Online articles</title><width>144</width><height>47</height><link>https://www.patientcareonline.com/news</link><url>https://www.patientcareonline.com/logo.webp</url></image><item><title>&lt;![CDATA[Nearly 80% of Young Adults Show Signs of CKM Syndrome, Study Finds]]&gt;</title><link>https://www.patientcareonline.com/view/nearly-80-of-young-adults-show-signs-of-ckm-syndrome-study-finds</link><guid isPermaLink="true">https://www.patientcareonline.com/view/nearly-80-of-young-adults-show-signs-of-ckm-syndrome-study-finds</guid><description>&lt;![CDATA[New research links cardiovascular-kidney-metabolic health stage to measurable arterial injury in adults as young as 23, with obesity the leading driver.]]&gt;</description><pubDate>Thu, 20 Aug 2026 18:26:37 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Authorizes Aletta Robotic Blood Draw Device for Outpatient Use]]&gt;</title><link>https://www.patientcareonline.com/view/fda-authorizes-aletta-robotic-blood-draw-device-for-outpatient-use</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-authorizes-aletta-robotic-blood-draw-device-for-outpatient-use</guid><description>&lt;![CDATA[FDA authorized Aletta, a robotic venous blood collection device for supervised outpatient use, through the De Novo pathway.]]&gt;</description><pubDate>Thu, 20 Aug 2026 10:19:36 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Dementia Prevention Research Expands Beyond Traditional Vascular Risk Factors]]&gt;</title><link>https://www.patientcareonline.com/view/dementia-prevention-research-expands-beyond-traditional-vascular-risk-factors</link><guid isPermaLink="true">https://www.patientcareonline.com/view/dementia-prevention-research-expands-beyond-traditional-vascular-risk-factors</guid><description>&lt;![CDATA[Josef Coresh, MD, discusses biomarkers, hearing correction, and integrated vascular care as emerging dementia prevention strategies. ]]&gt;</description><pubDate>Wed, 19 Aug 2026 19:54:51 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva]]&gt;</title><link>https://www.patientcareonline.com/view/fda-approves-garetosmab-for-adults-with-fibrodysplasia-ossificans-progressiva</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-approves-garetosmab-for-adults-with-fibrodysplasia-ossificans-progressiva</guid><description>&lt;![CDATA[FDA approved garetosmab for adults with FOP after phase 3 data showed fewer new HO lesions and clinician-assessed flare-ups vs placebo.]]&gt;</description><pubDate>Wed, 19 Aug 2026 19:32:12 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Grants Priority Review to First-in-Class Ecopipam for Pediatric Tourette Syndrome]]&gt;</title><link>https://www.patientcareonline.com/view/fda-grants-priority-review-to-first-in-class-ecopipam-for-pediatric-tourette-syndrome</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-grants-priority-review-to-first-in-class-ecopipam-for-pediatric-tourette-syndrome</guid><description>&lt;![CDATA[If approved, ecopipam would be the first new therapy indicated for pediatric patients with Tourette syndrome in more than 10 years. ]]&gt;</description><pubDate>Wed, 19 Aug 2026 17:24:20 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Comparing GnRH Agonists and Antagonists for Endometriosis Pain]]&gt;</title><link>https://www.patientcareonline.com/view/comparing-gnrh-agonists-and-antagonists-for-endometriosis-pain</link><guid isPermaLink="true">https://www.patientcareonline.com/view/comparing-gnrh-agonists-and-antagonists-for-endometriosis-pain</guid><description>&lt;![CDATA[In &quot;Comparing GnRH Agonists and Antagonists for Endometriosis Pain,&quot; Dr. Davitt explains the mechanistic split between two major drug classes used to manage endometriosis pain.]]&gt;</description><pubDate>Wed, 19 Aug 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Hypercortisolism Treatment and Earlier Recognition]]&gt;</title><link>https://www.patientcareonline.com/view/hypercortisolism-treatment-and-earlier-recognition</link><guid isPermaLink="true">https://www.patientcareonline.com/view/hypercortisolism-treatment-and-earlier-recognition</guid><description>&lt;![CDATA[Expert faculty discuss how treatment outcomes and emerging evidence strengthen the case for earlier recognition of   
hypercortisolism in primary care.]]&gt;</description><pubDate>Wed, 19 Aug 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Hypercortisolism Screening in Primary Care]]&gt;</title><link>https://www.patientcareonline.com/view/hypercortisolism-screening-in-primary-care</link><guid isPermaLink="true">https://www.patientcareonline.com/view/hypercortisolism-screening-in-primary-care</guid><description>&lt;![CDATA[Expert faculty demonstrate how practical hypercortisolism screening can be in primary care when clinicians know which test to use and how to use it.  ]]&gt;</description><pubDate>Wed, 19 Aug 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Why Estrogen Suppression Anchors Endometriosis Treatment]]&gt;</title><link>https://www.patientcareonline.com/view/why-estrogen-suppression-anchors-endometriosis-treatment</link><guid isPermaLink="true">https://www.patientcareonline.com/view/why-estrogen-suppression-anchors-endometriosis-treatment</guid><description>&lt;![CDATA[In &quot;Why Estrogen Suppression Anchors Endometriosis Treatment,&quot; the panel explores the biological rationale that makes estrogen suppression the backbone of medical therapy.]]&gt;</description><pubDate>Wed, 19 Aug 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Once-Weekly Insulin Icodec Offers a Major Shift in Type 2 Diabetes Care]]&gt;</title><link>https://www.patientcareonline.com/view/once-weekly-insulin-icodec-offers-a-major-shift-in-type-2-diabetes-care</link><guid isPermaLink="true">https://www.patientcareonline.com/view/once-weekly-insulin-icodec-offers-a-major-shift-in-type-2-diabetes-care</guid><description>&lt;![CDATA[A nurse practitioner discusses why once-weekly basal insulin matters, who benefits most, and how its starting doses differ from daily insulin.]]&gt;</description><pubDate>Tue, 18 Aug 2026 21:10:47 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Avexitide Reduced Hypoglycemic Events in Phase 3 Post-Bariatric Hypoglycemia Trial]]&gt;</title><link>https://www.patientcareonline.com/view/avexitide-reduced-hypoglycemic-events-in-phase-3-post-bariatric-hypoglycemia-trial</link><guid isPermaLink="true">https://www.patientcareonline.com/view/avexitide-reduced-hypoglycemic-events-in-phase-3-post-bariatric-hypoglycemia-trial</guid><description>&lt;![CDATA[Phase 3 LUCIDITY results showed avexitide reduced Level 2 and Level 3 hypoglycemic events by 55% vs placebo in post-bariatric hypoglycemia.]]&gt;</description><pubDate>Tue, 18 Aug 2026 12:58:45 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Approves Lerodalcibep Autoinjector for Hypercholesterolemia, Updated Indication]]&gt;</title><link>https://www.patientcareonline.com/view/fda-approves-lerodalcibep-autoinjector-for-hypercholesterolemia-updated-indication</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-approves-lerodalcibep-autoinjector-for-hypercholesterolemia-updated-indication</guid><description>&lt;![CDATA[The FDA approved an autoinjector device for lerodalcibep-liga and an updated indication reflecting cardiovascular risk reduction.]]&gt;</description><pubDate>Mon, 17 Aug 2026 14:10:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Reminders for Primary Care Physicians, Patients Improved Annual Lung Cancer Screening Adherence]]&gt;</title><link>https://www.patientcareonline.com/view/reminders-for-primary-care-physicians-patients-improved-annual-lung-cancer-screening-adherence</link><guid isPermaLink="true">https://www.patientcareonline.com/view/reminders-for-primary-care-physicians-patients-improved-annual-lung-cancer-screening-adherence</guid><description>&lt;![CDATA[Stepped reminders to PCPs and patients increased annual lung cancer screening adherence by 27.7 percentage points, according to new research. ]]&gt;</description><pubDate>Fri, 14 Aug 2026 15:49:21 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Relationship-Based Navigation Improves Resource Access in Primary Care Trial]]&gt;</title><link>https://www.patientcareonline.com/view/relationship-based-navigation-improves-resource-access-in-primary-care-trial</link><guid isPermaLink="true">https://www.patientcareonline.com/view/relationship-based-navigation-improves-resource-access-in-primary-care-trial</guid><description>&lt;![CDATA[Relationship-based navigation helped more primary care patients access health and social services than referral to a free information service. ]]&gt;</description><pubDate>Thu, 13 Aug 2026 15:12:39 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Freenome Lung Cancer Blood Test Receives FDA Breakthrough Device Status]]&gt;</title><link>https://www.patientcareonline.com/view/freenome-lung-cancer-blood-test-receives-fda-breakthrough-device-status</link><guid isPermaLink="true">https://www.patientcareonline.com/view/freenome-lung-cancer-blood-test-receives-fda-breakthrough-device-status</guid><description>&lt;![CDATA[The US FDA granted breakthrough device status to Freenome’s investigational blood test designed to triage high-risk adults for lung cancer screening.]]&gt;</description><pubDate>Wed, 12 Aug 2026 19:19:15 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[How Primary Care Physicians Can Target Midlife Vascular Risk to Support Brain Health]]&gt;</title><link>https://www.patientcareonline.com/view/how-primary-care-physicians-can-target-midlife-vascular-risk-to-support-brain-health</link><guid isPermaLink="true">https://www.patientcareonline.com/view/how-primary-care-physicians-can-target-midlife-vascular-risk-to-support-brain-health</guid><description>&lt;![CDATA[Josef Coresh, MD, PhD, discusses how primary care clinicians can address hypertension, diabetes, and smoking to support long-term cognitive health.]]&gt;</description><pubDate>Wed, 12 Aug 2026 13:28:41 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Weighing Surgical Versus Medical Management in Endometriosis]]&gt;</title><link>https://www.patientcareonline.com/view/weighing-surgical-versus-medical-management-in-endometriosis</link><guid isPermaLink="true">https://www.patientcareonline.com/view/weighing-surgical-versus-medical-management-in-endometriosis</guid><description>&lt;![CDATA[&quot;Weighing Surgical Versus Medical Management in Endometriosis&quot; takes up the question of when a patient&apos;s endometriosis care should shift from medicine to the operating room.]]&gt;</description><pubDate>Wed, 12 Aug 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[The Role of Hypercortisolism in Difficult-to-Control Type 2 Diabetes]]&gt;</title><link>https://www.patientcareonline.com/view/the-role-of-hypercortisolism-in-difficult-to-control-type-2-diabetes</link><guid isPermaLink="true">https://www.patientcareonline.com/view/the-role-of-hypercortisolism-in-difficult-to-control-type-2-diabetes</guid><description>&lt;![CDATA[The panel of experts examines how the CATALYST trial is changing the way primary care clinicians recognize hypercortisolism in patients with difficult-to-control type 2 diabetes.]]&gt;</description><pubDate>Wed, 12 Aug 2026 12:03:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Recognizing Hypercortisolism in Primary Care]]&gt;</title><link>https://www.patientcareonline.com/view/recognizing-hypercortisolism-in-primary-care</link><guid isPermaLink="true">https://www.patientcareonline.com/view/recognizing-hypercortisolism-in-primary-care</guid><description>&lt;![CDATA[Patients who keep missing treatment goals despite good therapy may be facing an unrecognized hormonal driver that primary care is now positioned to catch early.]]&gt;</description><pubDate>Wed, 12 Aug 2026 12:01:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Understanding the Different Types of Endometriosis Lesions]]&gt;</title><link>https://www.patientcareonline.com/view/understanding-the-different-types-of-endometriosis-lesions</link><guid isPermaLink="true">https://www.patientcareonline.com/view/understanding-the-different-types-of-endometriosis-lesions</guid><description>&lt;![CDATA[In &quot;Understanding the Different Types of Endometriosis Lesions,&quot; our experts turn to the primary goals of treatment and the disease&apos;s four distinct subtypes.]]&gt;</description><pubDate>Wed, 12 Aug 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[New Childhood Vaccine Executive Order Draws Criticism From AAP, AMA, NFID]]&gt;</title><link>https://www.patientcareonline.com/view/new-childhood-vaccine-executive-order-draws-criticism-from-aap-ama-nfid</link><guid isPermaLink="true">https://www.patientcareonline.com/view/new-childhood-vaccine-executive-order-draws-criticism-from-aap-ama-nfid</guid><description>&lt;![CDATA[The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.]]&gt;</description><pubDate>Tue, 11 Aug 2026 18:43:46 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Once-Weekly Insulin Icodec Enters US Market for Adults With Type 2 Diabetes]]&gt;</title><link>https://www.patientcareonline.com/view/once-weekly-insulin-icodec-enters-us-market-for-adults-with-type-2-diabetes</link><guid isPermaLink="true">https://www.patientcareonline.com/view/once-weekly-insulin-icodec-enters-us-market-for-adults-with-type-2-diabetes</guid><description>&lt;![CDATA[Insulin icodec is now available in the US after FDA approval, offering adults with type 2 diabetes a once-weekly basal insulin option.]]&gt;</description><pubDate>Tue, 11 Aug 2026 14:30:31 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Three Midlife Vascular Risk Factors Linked to 13 Fewer Dementia-Free Years in New Study]]&gt;</title><link>https://www.patientcareonline.com/view/three-midlife-vascular-risk-factors-linked-to-13-fewer-dementia-free-years-in-new-study</link><guid isPermaLink="true">https://www.patientcareonline.com/view/three-midlife-vascular-risk-factors-linked-to-13-fewer-dementia-free-years-in-new-study</guid><description>&lt;![CDATA[Corresponding author Josef Coresh, MD, PhD, explains how hypertension, diabetes, and smoking in midlife were linked to fewer dementia-free survival years.  ]]&gt;</description><pubDate>Mon, 10 Aug 2026 20:35:02 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[ABCL635 Reduced Vasomotor Symptom Frequency and Severity in Phase 2 Trial]]&gt;</title><link>https://www.patientcareonline.com/view/abcl635-reduced-vasomotor-symptom-frequency-and-severity-in-phase-2-trial</link><guid isPermaLink="true">https://www.patientcareonline.com/view/abcl635-reduced-vasomotor-symptom-frequency-and-severity-in-phase-2-trial</guid><description>&lt;![CDATA[Topline phase 2 data showed single-dose ABCL635 reduced moderate-to-severe vasomotor symptom frequency by 83% at week 4.]]&gt;</description><pubDate>Mon, 10 Aug 2026 13:56:37 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children]]&gt;</title><link>https://www.patientcareonline.com/view/fda-reviews-clesrovimab-for-second-season-rsv-prevention-in-high-risk-children</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-reviews-clesrovimab-for-second-season-rsv-prevention-in-high-risk-children</guid><description>&lt;![CDATA[FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.]]&gt;</description><pubDate>Fri, 07 Aug 2026 19:29:37 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[With Colonoscopy Capacity Limited, We Need More Momentum Behind Noninvasive Home-Based Tests, Says Mark Fendrick, MD ]]&gt;</title><link>https://www.patientcareonline.com/view/with-colonoscopy-capacity-limited-we-need-momentum-behind-noninvasive-home-based-tests-says-mark-fendrick-md</link><guid isPermaLink="true">https://www.patientcareonline.com/view/with-colonoscopy-capacity-limited-we-need-momentum-behind-noninvasive-home-based-tests-says-mark-fendrick-md</guid><description>&lt;![CDATA[Fendrick considers the current state of colorectal cancer screening in the US, emphasizing limited colonoscopy capacity and patient preferences for at-home tests.]]&gt;</description><pubDate>Fri, 07 Aug 2026 16:02:49 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1]]&gt;</title><link>https://www.patientcareonline.com/view/fda-approves-oveporexton-first-orexin-receptor-agonist-for-narcolepsy-type-1</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-approves-oveporexton-first-orexin-receptor-agonist-for-narcolepsy-type-1</guid><description>&lt;![CDATA[The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy. ]]&gt;</description><pubDate>Thu, 06 Aug 2026 18:41:17 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Integrating Social Determinants of Health Into Primary Care: A Team Based Population Health Approach]]&gt;</title><link>https://www.patientcareonline.com/view/integrating-social-determinants-of-health-into-primary-care-a-team-based-population-health-approach</link><guid isPermaLink="true">https://www.patientcareonline.com/view/integrating-social-determinants-of-health-into-primary-care-a-team-based-population-health-approach</guid><description>&lt;![CDATA[Community health workers and population health screening tactics help primary care teams address SDOH and reduce hospital utilization.]]&gt;</description><pubDate>Thu, 06 Aug 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[FDA Approves mRNA-1010 (mFLUSIVA) as First mRNA Flu Vaccine for Adults 50 and Older]]&gt;</title><link>https://www.patientcareonline.com/view/fda-approves-mrna-1010-mflusiva-as-mrna-flu-vaccine-for-adults-50-and-older</link><guid isPermaLink="true">https://www.patientcareonline.com/view/fda-approves-mrna-1010-mflusiva-as-mrna-flu-vaccine-for-adults-50-and-older</guid><description>&lt;![CDATA[The FDA has approved mFLUSIVA, Moderna&apos;s first mRNA flu vaccine, for adults 50 and older ahead of the 2026-2027 season.]]&gt;</description><pubDate>Thu, 06 Aug 2026 12:55:14 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item><item><title>&lt;![CDATA[Primary Care Lens: What HR 1 Means for Medicaid and Primary Care]]&gt;</title><link>https://www.patientcareonline.com/view/primary-care-lens-what-hr-1-means-for-medicaid-and-primary-care</link><guid isPermaLink="true">https://www.patientcareonline.com/view/primary-care-lens-what-hr-1-means-for-medicaid-and-primary-care</guid><description>&lt;![CDATA[Jubril Oyeyemi, MD, and Giridhar Mallya, MD, MSHP, unpack HR 1&apos;s Medicaid work requirements and what they mean for primary care practices.]]&gt;</description><pubDate>Wed, 05 Aug 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">Patient Care Online</media:credit><category>us</category><source url="https://www.patientcareonline.com/rss.xml">Patient Care Online Articles</source></item></channel></rss>